The Valley Desk

NCT03283371 · Interventional trial

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Overall registry status Completed

Phase 2

Conditions Epilepsy, Focal Seizures, Partial Seizures

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov